"Cereport" Treatment for Astrocytoma

Jane Alavi, MD and Jim Dattilo
Last Modified: November 1, 2001

Question:

My uncle was diagnosed as having a malignant astrocytoma brain tumor. His physician suggested researching "cereport" treatment. We have been unable to access any information on this therapy. Can you please explain this treatment and where we may find additional information? Also, are you aware of any other new or alternative treatments for this condition?
Thank you so much for your help.
SV

Answer:

Jane Alavi, MD and Jim Dattilo from the Brain Tumor Center at Abramson Cancer Center of the University of Pennsylvania respond:

One of the greatest obstacles in using chemotherapy is in drugs crossing the "blood brain barrier" - the protective filter of the brain that selectively controls what goes into the brain. The new drug, Cereport, is designed to temporarily open the "blood brain barrier" to allow drugs, such as chemotherapy, to enter the brain, and in turn give a better effect on treating the tumor. While Cereport has shown some promise in the laboratory and is now being tested in humans, it is still an investigational treatment and not widely available. We would recommend that you ask your physician to contact Alkermes, Inc, the drug manufacturer, to find out about clinical trials that are available for malignant astrocytoma.

Blogs

February 29th is Rare Disease Day
by Christina Bach, MSW, LCSW, OSW-C
February 26, 2016

The CancerLand Bookshelf: A Taste of Caregiver Poetry
by Alysa Cummings
January 18, 2012

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives